Perficient’s Post

If you're in the pharma and biotech space, you do not want to miss this event. Join us at Bloomberg's New York Headquarters to explore how Al is transforming the pharmaceutical industry. The potential for cost and time savings by integrating AI in the drug-development process is set to enhance companies' efforts to come up with new therapies, hastening the iterative cycles of designing, making, testing and analyzing compounds for clinical testing. This event brings together top leaders to discuss Al's impact across drug development — from target identification and preclinical acceleration to clinical trials, regulatory integration and commercialization. It will feature a keynote address and multiple panels featuring stakeholders from Insilico Medicine, Certara, Flagship Pioneering and Owkin. Join us on December 12 | 1:30 PM - 6:30 PM | New York Register here: https://bloom.bg/3CFcp8J #ai #pharma #regulation #innovation #biotech #tech #drugdiscovery #drugdevelopment #innovation #research

#Innovation has always been a big topic within the research industry, even more so now than ever, with the recent buzz around the potential of #ai and digitalisation in shaping the future of clinical research. If you're interested to learn more about current and future innovation within the #pharma sector, be sure to read Deloitte's latest report on "Measuring the return from pharmaceutical innovation" Furthermore, I am delighted to say that TrialHub has been prominently featured on ▪page 13▪, highlighting TrialHub’s pivotal role in revolutionizing clinical trial planning with our innovative data intelligence platform. Be sure to check out the full report LinkedIn in the comments below 👇 #TrialHub #ClinicalTrials #DigitalTransformation #InnovationInHealthcare #Biopharma #Deloitte #DeloitteReport #ClinicalResearch

Check out my latest article, “AI Revolutionizing Drug Discovery,” featured in Pharma Focus Europe, 5th Edition. I dive into how AI is transforming drug discovery processes in the lab, accelerating timelines, refining therapies, and ultimately bringing life-saving treatments to patients faster. If you’re curious about the future of labs and how AI is reshaping the pharmaceutical landscape, give it a read! A big thank you to Pharma Focus Europe for this amazing opportunity to share my perspective. #PharmaFocusEurope #DrugDiscovery #AIInPharma #LabInnovation

Top Pharma Stocks Riding on AI Innovation https://lnkd.in/gyA5nxeY 🚀 Unleashing the Power of AI in Pharma! 🚀 The pharmaceutical industry is in the midst of a technological revolution, with AI leading the way in drug discovery and development. Companies like Pfizer, Roche, and AstraZeneca are harnessing artificial intelligence to accelerate research, optimize clinical trials, and enhance patient care. 📈 Dive into our latest analysis of the top pharma stocks riding the wave of AI innovation and discover how these industry giants are positioning themselves for success in 2025 and beyond! 🌟 #AIInPharmaceuticals #TopPharmaStocks2025 #DrugDiscoveryTechnology #PfizerStock #RocheStock

In this Short Take, Mark Bard (DHC Group) and Shwen Gwee (#GenAI4Pharma) discuss the transformative potential of generative AI in the pharmaceutical industry. From early research to patient support, AI is creating opportunities for innovation and efficiency across functions like drug development, creative content, and more. Watch the clip to explore how AI is shaping the future of pharma—and join the conversation by clicking the link for additional insights. https://lnkd.in/eRT2KgFJ

🚀 Accelerating Drug Discovery with AI! 🚀 I recently attended an insightful seminar by Clinosol on "The Role of AI in Accelerating Drug Discovery and Approval Process" 📚 The seminar showcased the transformative potential of Artificial Intelligence in revolutionizing the pharmaceutical industry 💡. Key takeaways included: 🔹 AI-driven approaches to accelerate target identification, lead optimization, and clinical trials 🔹 The importance of data quality, curation, and standardization in AI-powered drug discovery 🔹 Regulatory frameworks and challenges associated with AI adoption in pharmaceuticals The event featured expert speakers who shared their experiences and insights on leveraging AI to drive innovation, efficiency, and patient-centricity in drug development 💊. I'm excited to explore the possibilities of AI in accelerating drug discovery and approval processes 🎯. Thank you, Clinosol, for organizing this informative seminar! 🙏 #AIinPharma #DrugDiscovery #Innovation #Pharmaceuticals #Healthcare #Clinosol 💻

#podcast Shai Shen-Orr, the Co-Founder and Chief Scientist of CytoReason, is developing computational disease models powered by AI to improve the probability of success in phase 2 clinical trials. Their goal is to more precisely develop drugs using AI to analyze large amounts of biological and clinical data and overcome the challenges of the complexity and uncertainty in medical information. Working with large pharmaceutical companies, CytoReason is supporting companies in their drug development efforts and helping them choose the right drug target and patient populations to study.   #CytoReason #PharmaAI #AI #DrugDiscovery #DrugDevelopment #ClinicalTrials cytoreason.com https://lnkd.in/gXW7gadF

Revolutionizing Pharma with Generative AI! Explore how Generative AI is transforming drug development and clinical trials, accelerating breakthroughs in the pharmaceutical industry. Discover the future in our latest blog! https://bit.ly/47DacG2 #GenerativeAI #PharmaTech #DrugDevelopment #AIInHealthcare #techblog

🚀 Excited to share my latest article on "AI-Driven Drug Discovery: Accelerating Pharmaceutical Research"! 🧬💊 AI is revolutionizing the pharmaceutical industry by enhancing efficiency, accuracy, and cost-effectiveness in drug discovery. This article explores how AI is transforming various stages of drug development, including: 💉Target Identification and Validation: Leveraging AI to uncover novel drug targets. 💉Hit Identification: Using AI models to screen vast chemical libraries and predict compound interactions. 💉Lead Optimization: Generative AI designing new molecules with desired properties. 💉Preclinical Testing: Predicting pharmacokinetics and toxicity with machine learning. 💉Clinical Trials: Improving trial design, patient cohort identification, and real-time monitoring. With case studies from Insilico Medicine, BenevolentAI, and Atomwise, this article highlights real-world applications and the potential of AI to bring effective treatments to market faster. Discover how AI is driving a new era of rapid and cost-effective drug development. Read the full article here: https://lnkd.in/gVtP3UmY. #ArtificialIntelligence #DrugDiscovery #Pharmaceuticals #MachineLearning #HealthcareInnovation #AIinPharma

Everyone is talking about #GenAI and the opportunities it brings us. As you know, I have been evangelizing with Analytics in the retail and manufacturing industry for many years. The pharmaceutical industry, always one step ahead, is now ready to share its insights. I am excited to invite you to this exclusive event on May 7, where you can hear how Bayer, ViiV Healthcare (GSK) and argenx use this technology, which is highly relevant to our industries. For example, there is a lot of talk about #SyntheticData as an example of GenAI; You know that the pharmaceutical industry has been using it for a long time. This event will not only discuss these concepts but also provide practical insights on how to implement them. #sas #supplychain #genai https://lnkd.in/dvrkMuN8 moderate by Kayt Leonard